Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

599
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
599
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

268
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
268
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

492
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
492
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

319
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
319
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

855
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
855
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.1K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Amnesic stroke].

La Revue du praticien·2026
Same author

The role of evidence-based medicine in the media: misinformation and the COVID-19 lesson.

European respiratory review : an official journal of the European Respiratory Society·2025
Same author

Practice Variations in the Diagnosis and Treatment of Pulmonary Embolism.

Pulmonary medicine·2024
Same author

Expert views on screening for tuberculosis infection in patients commencing treatment with a biologic agent.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2024
Same author

Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio-sampling of the lower airways in children and adults.

Respirology (Carlton, Vic.)·2024
Same author

[Post-zoster segmental abdominal paralysis].

La Revue du praticien·2023

Related Experiment Video

Updated: Nov 15, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.9K

What pulmonologists need to know about extrapulmonary tuberculosis.

Delphine Natali1, Georges Cloatre2, Christian Brosset3

  • 1Respiratory Medicine, Hanoi French Hospital, Hanoi, Vietnam.

Breathe (Sheffield, England)
|March 5, 2021
PubMed
Summary

Extrapulmonary tuberculosis (EPT) is difficult to diagnose when it doesn't affect the lungs. This review covers EPT's clinical signs, diagnostic methods, and treatment strategies for various organ involvements.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.0K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.5K

Related Experiment Videos

Last Updated: Nov 15, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.9K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.0K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.5K

Area of Science:

  • Medical research
  • Infectious diseases
  • Pulmonology

Background:

  • Extrapulmonary tuberculosis (EPT) affects organs beyond the lungs, posing diagnostic challenges.
  • Certain EPT presentations, like central nervous system involvement, are medical emergencies.
  • The location of EPT influences treatment protocols and duration.

Purpose of the Study:

  • To review the clinical features of extrapulmonary tuberculosis.
  • To outline diagnostic approaches for EPT.
  • To summarize current treatment regimens for EPT.

Main Methods:

  • Literature review of clinical studies on EPT.
  • Analysis of diagnostic modalities for extrapulmonary TB.
  • Synthesis of treatment guidelines and reported outcomes.

Main Results:

  • EPT diagnosis is complex, particularly without lung involvement.
  • Specific EPT sites necessitate urgent intervention and tailored therapy.
  • A range of diagnostic tests are available, varying in efficacy by site.

Conclusions:

  • Early recognition of EPT clinical manifestations is crucial.
  • Appropriate diagnostic testing aids timely and effective treatment.
  • Management of EPT requires a comprehensive understanding of its diverse presentations and treatment options.